This is the Theranos pitch deck used to raise $28.5m series-C, what it referred to as a “pre-IPO transaction.” Two years later would be valued by investors at $9 billion
Theranos has raised $686.3M in 9 Rounds from 17 Investors.
Interestingly they already refer to their product accuracy as comparable to “gold standards.”
The deck is highly technical. What one might typically expect from a biotech company? This is more interesting from an intriguing perspective, rather than for learning how to write decks.
About Theranos
Theranos (allegedly) makes actionable health information accessible to everyone at the time it matters.
Headquartered in Palo Alto, Theranos, Inc. is a consumer healthcare technology company. Theranos’ clinical laboratory offers comprehensive laboratory tests from samples as small as a few drops of blood at unprecedented low prices. Founded in 2003 by Elizabeth Holmes, Theranos’ mission is to make actionable health information accessible to people everywhere in the world at the time it matters, enabling early detection and intervention of disease, and empowering individuals with information to live the lives they want to live.
Funding Rounds
| Date | Amount / Round | Valuation | Lead Investor | Investors |
|---|---|---|---|---|
| Dec, 2016 | undisclosed amount /Venture | — | — | 1 |
| Mar, 2015 | $348.5M / Private Equity | — | — | 9 |
| Feb, 2014 | $198.9M / Private Equity | — | — | 0 |
| Sep, 2013 | $50M / Undisclosed | — | Walgreens | 1 |
| Jul, 2010 | $45M / Venture | — | — | 0 |
| Nov, 2006 | $28.5M / Series C | — | — | 4 |
| Feb, 2006 | $9.1M / Series B | — | — | 1 |
| Feb, 2005 | $5.8M / Series A | — | — | 1 |
| Jun, 2004 | $500k / Seed | — | Draper Fisher Jurvetson (DFJ) | 1 |
Theranos Pitch Deck
Deck Collection
See the rest of the collection here:
Comments (0)
There are no comments yet :(